Core Viewpoint - The surge in taurine prices and the popularity of functional beverages have significantly driven the stock price of Yong'an Pharmaceutical, which has seen a remarkable increase in recent weeks [2][9]. Group 1: Taurine Market Dynamics - Yong'an Pharmaceutical, the largest taurine producer globally, is projected to achieve approximately 635 million yuan in revenue from taurine raw materials in 2024, accounting for 75.69% of total revenue [7]. - Recent international taurine prices have exceeded $10 per kilogram, driven by trade war price expectations and U.S. regulations mandating taurine in infant formula and pet food [7][8]. - The global demand for taurine is estimated at 160,000 tons annually, while current production capacity is only 140,000 tons, resulting in a shortfall of about 20,000 tons [8]. Group 2: Functional Beverage Market Entry - Yong'an Pharmaceutical has successfully entered the functional beverage market, contributing to its recent stock price surge [9]. - The company's solid functional beverage brand, Yijianeng, has achieved significant sales, ranking first in popularity on various e-commerce platforms [10]. - The functional beverage market in China is projected to grow to 166.5 billion yuan by 2024, with a compound annual growth rate of 8.3% from 2019 to 2024, indicating substantial growth potential [10][11]. Group 3: Strategic Initiatives - The company has focused on the anti-fatigue market for its functional beverage offerings, with plans to launch its self-branded products by the end of 2024 [11]. - Yong'an Pharmaceutical is actively involved in the research, development, and production of taurine-based functional foods and health products [11].